A Mombasa court found Mackenzie and 28 followers guilty over the Shakahola forest starvation deaths, delivering the first murder verdict in a case that has haunted Kenya since mass graves were found in 2023.
Two of the stock market's steadiest performers report before Tuesday's opening bell, kicking off a week of results investors will use to judge whether Monday's AI-stock rebound has real legs.
A tally that has circulated widely this month shows U.S. startups chasing the power and computing limits of the AI boom have already raised nearly double what they did in all of 2025, with the bank warning that raising cash is the easy part.
Brent eased from a high not seen since May after an executive order loosened sanctions tied to Russian energy exports, but tanker attacks near the Strait of Hormuz are keeping a floor under the market.
A weekend intrusion at a legacy system let hackers run up victims' AI bills, in an incident that echoes a growing pattern of security tools unable to analyze their own attackers.
Pooling data on nearly 16 million people, researchers found ADHD tied to sharply higher mortality from suicide, injury and natural causes — with treatment linked to better odds.
A Columbia University team says a mutation in the fibronectin gene keeps the brain's blood vessels from clogging — and could point toward a new kind of drug.
A University of Warwick survey of dead stars within 65 light-years of Earth has turned up a cosmic rarity — and hints that there could be many more.
"You Can See Everything," made with unusual access to the disgraced Theranos founder in the weeks before she reported to prison, opened to one of the year's strongest per-theater averages — and A24 is about to widen it nationwide.